The first Calithera Biosciences trade was made in Q4 2019.
Since then PRIMECAP Management bought shares six more times and sold shares on six occasions. The investor completely sold their stake between Q2 2022 and Q1 2023.
Avg closing price
Price range
Sold -401 Thousand shares
Q1 2023
Avg closing price
$0.39
Price range
$0.04
-
$3.62
Sold 3.2% shares (-13.4 Thousand shares)
Q4 2022
Avg closing price
$2.39
Price range
$1.36
-
$3.26
Sold 1.4% shares (-5.8 Thousand shares)
Q3 2022
Avg closing price
$3.42
Price range
$2.42
-
$4.88
Sold 21.7% shares (-116 Thousand shares)
Q2 2022
Avg closing price
$4.64
Price range
$2.41
-
$7.34
Increased shares by 1.2% (+6.22 Thousand shares)
Q4 2021
Avg closing price
$25.13
Price range
$12.49
-
$42.40
Increased shares by 2.6% (+13.3 Thousand shares)
Q3 2021
Avg closing price
$43.14
Price range
$37.20
-
$49.00
Increased shares by 0.1% (+500 shares)
Q2 2021
Avg closing price
$43.94
Price range
$39.20
-
$50.00
Increased shares by 0.8% (+4.01 Thousand shares)
Q1 2021
Avg closing price
$58.20
Price range
$47.80
-
$73.20
Increased shares by 1.9% (+9.6 Thousand shares)
Q4 2020
Avg closing price
$87.64
Price range
$69.80
-
$117.40
Sold 0.1% shares (-315 shares)
Q3 2020
Avg closing price
$87.25
Price range
$67.20
-
$109.80
Increased shares by 6.5% (+30.6 Thousand shares)
Q2 2020